Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Oct 30;9(10):e032710.
doi: 10.1136/bmjopen-2019-032710.

Optimised transcranial direct current stimulation (tDCS) for fibromyalgia-targeting the endogenous pain control system: a randomised, double-blind, factorial clinical trial protocol

Luis Castelo-Branco  1 , Elif Uygur Kucukseymen  1 , Dante Duarte  1 , Mirret M El-Hagrassy  1 , Camila Bonin Pinto  1 , Muhammed Enes Gunduz  1 , Alejandra Cardenas-Rojas  1 , Kevin Pacheco-Barrios  1 , Yiling Yang  1 , Paola Gonzalez-Mego  1 , Anayali Estudillo-Guerra  1 , Ludmilla Candido-Santos  1 , Ines Mesia-Toledo  1 , Haley Rafferty  1 , Wolnei Caumo  2 , Felipe Fregni  3
Affiliations

Optimised transcranial direct current stimulation (tDCS) for fibromyalgia-targeting the endogenous pain control system: a randomised, double-blind, factorial clinical trial protocol

Luis Castelo-Branco et al. BMJ Open. .

Abstract

Introduction: Fibromyalgia (FM) is a common debilitating condition with limited therapeutic options. Medications have low efficacy and are often associated with adverse effects. Given that FM is associated with a defective endogenous pain control system and central sensitisation, combining interventions such as transcranial direct current stimulation (tDCS) and aerobic exercise (AE) to modulate pain-processing circuits may enhance pain control.

Methods and analysis: A prospective, randomised (1:1:1:1), placebo-controlled, double-blind, factorial clinical trial will test the hypothesis that optimised tDCS (16 anodal tDCS sessions combined with AE) can restore of the pain endogenous control system. Participants with FM (n=148) will undergo a conditioning exercise period and be randomly allocated to one of four groups: (1) active tDCS and AE, (2) sham tDCS and AE, (3) active tDCS and non-aerobic exercise (nAE) or (4) sham tDCS and nAE. Pain inhibitory activity will be assessed using conditioned pain modulation (CPM) and temporal slow pain summation (TSPS)-primary outcomes. Secondary outcomes will include the following assessments: Transcranial magnetic stimulation and electroencephalography as cortical markers of pain inhibitory control and thalamocortical circuits; secondary clinical outcomes on pain, FM, quality of life, sleep and depression. Finally, the relationship between the two main mechanistic targets in this study-CPM and TSPS-and changes in secondary clinical outcomes will be tested. The change in the primary efficacy endpoint, CPM and TSPS, from baseline to week 4 of stimulation will be tested with a mixed linear model and adjusted for important demographic variables.

Ethics and dissemination: This study obeys the Declaration of Helsinki and was approved by the Institutional Review Board (IRB) of Partners Healthcare under the protocol number 2017P002524. Informed consent will be obtained from participants. Study findings will be reported in conferences and peer-reviewed journal publications.

Trial registration number: NCT03371225.

Keywords: aerobic exercise; conditioned pain modulation; endogenous pain control system; fibromyalgia; temporal slow pain summation; transcranial direct current stimulation.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
Flowchart of the study based on CONSORT criteria. AE, aerobic exercise; nAE, non-aerobic exercise; tDCS, transcranial direct current stimulation.
Figure 2
Figure 2
Schematic view of the timeline. tDCS, transcranial direct current stimulation.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Wolfe F, Brähler E, Hinz A, et al. . Fibromyalgia prevalence, somatic symptom reporting, and the dimensionality of polysymptomatic distress: results from a survey of the general population. Arthritis Care Res 2013;65:777–85. 10.1002/acr.21931 - DOI - PubMed
    1. Verbunt JA, Pernot DHFM, Smeets RJEM. Disability and quality of life in patients with fibromyalgia. Health Qual Life Outcomes 2008;6:8 10.1186/1477-7525-6-8 - DOI - PMC - PubMed
    1. Robinson RL, Birnbaum HG, Morley MA, et al. . Economic cost and epidemiological characteristics of patients with fibromyalgia claims. J Rheumatol 2003;30:1318–25. - PubMed
    1. Adams N, Sim J. Rehabilitation approaches in fibromyalgia. Disabil Rehabil 2005;27:711–23. 10.1080/09638280400014709 - DOI - PubMed
    1. Häuser W, Walitt B, Fitzcharles M-A, et al. . Review of pharmacological therapies in fibromyalgia syndrome. Arthritis Res Ther 2014;16 10.1186/ar4441 - DOI - PMC - PubMed

Publication types

Associated data